Back to 
FIL Ltd
FIL Ltd
HALO
Showing 0 of 6 quarters
Position history for FIL Ltd's holdings in Halozyme Therapeutics, Inc.
No. FIL exited its HALO (Halozyme Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 39,161 shares worth $1.5M. FIL first reported HALO in Q3 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.